As part of a multi-product collaboration, Asimov’s CHO Edge system enabled a high performance cell line for a first-in-class bispecific antibody, achieving clonal titers of over 10 g/L in a platform ...

Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.

Researchers at the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures have, for the first time, identified a model cell line for a rare form of acute myeloid leukemia (AML).

UCLA's AlloESO-T cell therapy targets solid tumors at an estimated $5,000 per dose — a fraction of current costs — but remains in preclinical mouse trials only.

Learn how strategic CHO cell line development accelerates biologics timelines and supports clinical progression with flexible ...

Viral vector-based gene therapies hold immense promise for treating a multitude of diseases. However, their widespread adoption has been hindered by inefficient manufacturing methods and the absence ...

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...

Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products. The team, from the Technical University of Denmark (DTU), says they’ve ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...